Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

ABSTRACT:

SUBMITTER: Deng Q 

PROVIDER: S-EPMC6304452 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature